Theme issue: Fibrinogen and fibrin - Sructure, function, interactions and clinical applications

Thrombosis and Haemostasis

Volumn 89, Issue 4, 2003, Pages 599-600

  Dempfle, Carl Erik ^a   Mossesson, Michael W ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRIN DERIVATIVE; FIBRIN GLUE; FIBRINOGEN; FIBRINOPEPTIDE A; PLASMINOGEN ACTIVATOR; THROMBIN; TISSUE ADHESIVE; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; CORONARY ARTERY DISEASE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EDITORIAL; FIBRIN CLOT; FIBRIN FORMATION; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG EMBOLISM; PEER REVIEW; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; THROMBOEMBOLISM; VASCULAR DISEASE; WORKSHOP; WOUND;

EID: 0037395273     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613565     Document Type: Editorial

References (17)

1. Medved L, Nieuwenhuizen W. Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost 2003; 89: 409-19.
2. Shainoff JR, DiBello PM. The circulatory half-lives of alpha-profibrin and alpha-fibrin monomer, and comparisons with other fibrin(ogen) derivatives. Thromb Haemost 2003; 89: 48-52.
3. Shainoff JR, DiBello PM. Fibrin precursors, intermediaries for hemostasis in the clot war. Thromb Res 2002; 105: 3-13.
4. Meyer M, Franke K, Richter W, et al. New molecular defects in the γ subdomain of fibrinogen D-domain in four cases of (hypo) dysfibrinogenemia. Thromb Haemost 2003; 89: 637-46.
5. Amiconi G, Caracciolo G, De Spirito M, et al. Protofibrils within fibrin fibres are packed together in a regular tetragonal array. Thromb Haemost 2003; 89: 632-6.
6. Ferri F, Greco M, Arcovito G, De Spirito M, Rocco M. Structure of fibrin gels studied by elastic light scattering techniques: Dependence of fractal dimension, gel crossover length, fiber diameter, and fiber density on monomer concentration. Phys Rev E Stat Nonlin Soft Matter Phys 2002; 66(1): 011913.
7. Ramstrom S, Ranby M, Lindahl TL. The role of platelets in blood coagulation - Effects of platelet agonists and GPIIb/IIIa inhibitors studied by free oscillation rheometry. Thromb Res 2002; 105: 165-72.
8. Meh DA, Siebenlist KR, Brennan SO, Holyst T, Mosesson MW. The amino acid sequence in fibrin responsible for high affinity thrombin binding. Thromb Haemost 2001; 85: 470-4.
9. De Bosch NB, Mosesson MW, Ruiz-Saez A, Echenagucia M, Rodriguez-Lemoin A. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost 2002; 88: 253-8.
10. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003; 89: 9-12.
11. Lovely RS, Falls LA, Al-Mondhiry HA, et al. Association of γA/γ' fibrinogen levels and coronary artery disease. Thromb Haemost 2002; 88: 26-31.
12. Koenig W. Fibrin(ogen) in cardiovascular disease. Thromb Haemost 2003; 89:
13. Koenig W, Rothenbacher D, Hoffmeister A, Griesshammer M, Brenner H. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: Results of a large case-control study. Arterioscler Thromb Vasc Biol 2001; 21: 1701-5.
14. Pfaffenberger S, Devcic-Kuhar B, El-Rabadi K, et al. 2MHz ultrasound enhances t-PA-mediated thrombolysis: Comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves. Thromb Haemost 2003; 89: 583-9.
15. Ruppert C, Markart P, Schmidt R, et al. Chemical crosslinking of urokinase to pulmonary surfactant protein B for targeting alveolar fibrin. Thromb Haemost 2003; 89: 53-64.
16. Wong C, Inman E, Spaethe R, Helgerson S. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 2003;89: 573-82.
17. Taylor FB, Jr., Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.